Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | 105.80K | 106.10K | 104.40K | 102.20K | 113.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 105.80K | 106.10K | 104.40K | 102.20K | 113.20K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 105.80K | 106.10K | 104.40K | 102.20K | 113.20K |
| SG&A Expenses | 4.60M | 4.29M | 3.87M | 4.21M | 5.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.08M | 11.31M | 10.88M | 9.96M | 9.41M |
| Operating Income | -10.98M | -11.21M | -10.78M | -9.86M | -9.29M |
| Income Before Tax | -10.96M | -12.46M | -14.91M | -16.09M | -14.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.96 | -12.46 | -14.91 | -16.09 | -14.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.96M | -12.46M | -14.91M | -16.09M | -14.47M |
| EBIT | -10.98M | -11.21M | -10.78M | -9.86M | -9.29M |
| EBITDA | -10.96M | -11.19M | -10.77M | -9.59M | -9.02M |
| EPS Basic | -7.66 | -8.01 | -8.10 | -7.71 | -6.22 |
| Normalized Basic EPS | -2.55 | -2.91 | -3.60 | -3.89 | -3.79 |
| EPS Diluted | -7.66 | -8.01 | -8.10 | -7.71 | -6.22 |
| Normalized Diluted EPS | -2.55 | -2.91 | -3.60 | -3.89 | -3.79 |
| Average Basic Shares Outstanding | 10.35M | 10.35M | 10.35M | 10.35M | 10.35M |
| Average Diluted Shares Outstanding | 10.35M | 10.35M | 10.35M | 10.35M | 10.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
